��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2005, 31(6) 364-366 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��м��
	�׸л��
	��
	��
	��ѧ��
	��ɭ
	PubMed
	Article by
	Article by
	Article by

��м��׸л��о��չ

��, ��ѧ��, ��ɭ

��ҽ�ƴ�ѧƤ��о��һ��ҽԺƤ�� Ϸ� 230022

ժҪ��

��Ŷ��򼲲��о��Ĳ��Ͻ��,��м��׸л��Ŵ�ѧ�о�ȡ��˺ܴ��չ��򼲲��漰��,��Ȼ��Ϸ��µ��׸�λ��,��Ѱ��м��׸л��ϻ�û��ȡ��ͻ�ơ��Ŀǰ��м��׸л��о��չ��һ��

�ؼ���� м�� ׸л��

Abstract:

Keywords:

�ո�� 2005-03-02 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Orru S, Giuressi E, Carcassi C, et al. Mapping of the major psoriasis-susceptibility locus (PSORS1) in a 70-Kb interval around the corneodesmosin gene (CDSN). Am J Hum Genet, 2005, 76:164-171.
[2] Speckman RA, Wright Daw JA, Helms C, et al. Novel immunoglobulin superfamily gene cluster, mapping to a region of human chromosome 17q25, linked to psoriasis susceptibility. Hum Genet, 2003, 112:34-41.
[3] Capon F, Semprini S, Chimenti S, et al. Fine mapping of the PSORS4 psoriasis susceptibility region on chromosome 1q21. J Invest Dermatol, 2001, 116:728-730.
[4] Capon F, Allen MH, Ameen M, et al. A synonymous SNP of the comeodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet, 2004, 13:2361-2368.
[5] Elomaa O, Majuri I, Suomela S, et al. Transgenic mouse models support HCR as an effector gene in the PSORS1 locus. Hum MolGenet, 2004, 13:1551-1561.
[6] Holm SJ, Carlen LM, Mallbris L, et al. Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp Dermatol, 2003, 12:435-444.
[7] Foerster J, Nolte I, Junge J, et al. Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis. J Invest Dermatol, 2005, 124:99-102.
[8] Helms C, Cao L, Krueger JG, et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet, 2003, 35:349-356.
[9] Capon F, Helms C, Veal CD, et al. Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J Med Genet, 2004, 41:459-460.
[10] Sagoo GS, Tazi-Ahnini R, Barker JW, et al. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans popul ation. J Invest Dermatol, 2004, 122:1401-1405.
[11] Villadsen LS, Schuurman J, Beurskens F, et al. Resolution of psori asis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest, 2003, 112:1571-1580.
[12] Baker BS, Ovigne JM, Powles AV, et al. Normal keratinocytes ex press Toll-like receptors (TLRs) 1, 2 and 5:modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol, 2003, 148:670-679.
[13] Young HS, Summers AM, Bhushan M, et al. Single-nucleotide poly morphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol, 2004, 122:209-215.
[14] Foerster J, Nolte I, Schweiger S, et al. Evaluation of the IRF-2 gene as a candidate for PSORS3.J Invest Dermatol, 2004, 122:61-64.
[15] Parkinson J, Charon C, Baker BS, et al. Variation at the IRF2 gene and susceptibility to psoriasis in chromosome 4q-linked families. J Invest Dermatol, 2004, 122:640-643.
[16] Giardina E, Capon F, De Rosa MC, et al. Characterization of theloricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet, 2004, 68:639-645.
[17] Samuelsson L, Stiller C, Friberg C, et al. Association analysis of cystatin A and zinc finger protein 148, two genes located at the psoriasis susceptibility locus PSORS5. J Invest Dermatol, 2004, 122:1399-1400.
[18] Donn RP, Plant D, Jury F, et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Invest Dermatol, 2004, 123:484-487.
[19] Luszczek W, Manczak M, Cislo M, et al. Gene for the activatingnatural killer cell receptor, KIR2DS1, is associated with susceptibi lity to psoriasis vulgaris. Hum Immunol, 2004, 65:758-766.
[20] Rahman P, Bartlett S, Siannis F, et al. CARD15:a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet, 2003, 73:677-681.
[21] Giardina E, Novelli G, Costanzo A, et al. Psoriatic arthritis and CARD15 gene polymorphisms:no evidence for association in theIalian population. J Invest Dermatol, 2004, 122:1106-1107.
[22] Reich K, Mossner R, Konig IR, et al. Promoter polymorphisms of the genes encoding tumor necrosis factor-alpha and interleukin1beta are associated with different subtypes of psoriasis characteri zed by early and late disease onset. J Invest Dermatol, 2002, 118:155-163.
[23] Hensen P, Asadullah K, Windemuth C, et al. Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis. Br J Dermatol, 2003, 149:381-385.
[24] Kingo K, Koks S, Nikopensius T, et al. Polymorphisms in the interleukin-20 gene:relationships to plaque-type psoriasis. Genes Immun, 2004, 5:117-121.
[25] Koks S, Kingo K, Ratsep R, et al. Combined haplotype analysis of the interleukin-19 and-20 genes:relationship to plaque-type psoriasis. Genes Immun, 2004, 5:662-667.